Companies: 10,795·Total market cap: $144.5T
Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc.

RPIDNASDAQHealthcare● Active
$1.98
$-0.01(-0.50%)
Market Cap$89738114
P/E Ratio
52W High$4.94
52W Low$1.86

Rapid Micro Biosystems, Inc. (RPID) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

rpid · stock forecast · 6 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 6 Wall Street analysts in the past 3 months

SellBuy

Buy

6 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
4
Hold
2
Sell
0
Strong Sell
0
Total: 6 · Buy rate: 66.7%

12-Month Price Target

High

$7.00

Consensus

$7.00

+251.8% upside

Low

$7.00

Median: $7 · Last Close: $1.99

The Rapid Micro Biosystems, Inc. (RPID) analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month RPID price target is $7.00, representing +251.8% upside from the current price of $1.99.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$1.923.48%

1-day model range: $1.89–$1.95. Peak: $1.95 (-3.48%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-7.6%
2028-11.0%
2029-12.7%
2030-13.5%
2031-14.0%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)54.0
MACDBEARISH

Moving Averages · RPID · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$1.98BUY
MA 10$1.99BUY
MA 20$2.10SELL
MA 50$2.23SELL
MA 100$3.02SELL
MA 200$3.16SELL
Current $RPID · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.99BUY
EMA 10$2.01SELL
EMA 20$2.09SELL
EMA 50$2.35SELL
EMA 100$2.70SELL
EMA 200$2.89SELL
Current $RPID · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Keybanc2026-05-29
Maintains
OverweightOverweight
Lake Street2026-05-22
Maintains
BuyBuy
Morgan Stanley2023-03-07
Maintains
Equal WeightEqual Weight
JP Morgan2022-08-16
Downgrade ↓
OverweightNeutral
Morgan Stanley2022-05-11
Maintains
Equal WeightEqual Weight
Morgan Stanley2022-03-07
Maintains
Equal WeightEqual Weight
Morgan Stanley2022-02-15
Maintains
Equal WeightEqual Weight
Morgan Stanley2021-11-15
Maintains
Equal WeightEqual Weight
Stifel2021-08-09
Maintains
BuyBuy
Morgan Stanley2021-08-09
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on Rapid Micro Biosystems, Inc. (RPID) stock. Of the recent 12 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover RPID.

Analyst Recommendation Trends

Buy ratings02↑ +2
Hold ratings101
Sell ratings00

RPID analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$34M

↓ 27.8% YoY

Revenue Next Year

$39M

↑ 16.8% YoY

EPS This Year

$-1.01

EPS Next Year

$-0.93

↓ 7.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RPID EPS of $-1.01 for the current fiscal year, based on estimates from 2 analysts. The RPID revenue forecast is $34M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The RPID stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RPID price target is $7.00 (+251.8% upside), with an analyst consensus of Buy.

The RPID short-term stock prediction for tomorrow is $1.92 (-3.48%). The RPID stock prediction for 2030 projects a range of $2–$2.

Rapid Micro Biosystems, Inc. trades on NASDAQ under the ticker RPID. The RPID stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

RPID forecast · 8 questions

According to 6 Wall Street analysts, the average 12-month RPID price target is $7.00, with a high forecast of $7.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +251.8% potential upside from the current price of $1.99.

RPID price targetWhat is RPID price targetRPID analyst price targetRPID 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.